SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Raven McCloud who wrote (597)3/31/1999 5:38:00 PM
From: WTSherman  Respond to of 2515
 
<And at this point in time this runup is
on pure speculation. The preclinical
trials mean jack. IMCl has a long, long
way to go, IMO.<

Raven, I must be missing something here... Of course, the stock is a "speculation" and, of course, it has a long way to go. But, if it was obvious that the company had one or more highly effective cancer drugs the stock would not be at $16 or $13 or whatever that ended in "teen".



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News